Cleared Traditional

K211127 - Full Automatic (NIBP) Blood Pressure Mo...

K211127 is the FDA 510(k) clearance for Full Automatic (NIBP) Blood Pressure Mo... by Health & Life Co., Ltd.. It is a Class 2 Cardiovascular device (product code DXN) cleared through the Traditional 510(k) pathway after a 145-day FDA review.

K211127 · Health & Life Co., Ltd. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2021
Decision
145d
Days
Class 2
Risk

K211127 is an FDA 510(k) clearance for the Full Automatic (NIBP) Blood Pressure Monitor, Model HL858DM. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Health & Life Co., Ltd. (New Taipei, TW). The FDA issued a Cleared decision on September 8, 2021 after a review of 145 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Health & Life Co., Ltd. devices

Submission Details

510(k) Number K211127 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 16, 2021
Decision Date September 08, 2021
Days to Decision 145 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
20d slower than avg
Panel avg: 125d · This submission: 145d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 500
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K211127.
Arm Blood Pressure Monitor
K210563 · Alicn Medical (Shenzhen), Inc. · Oct 2021
Ambulatory Blood Pressure Monitor, Models: SA-10, SA-05, SA-06, SA-08 and SA-09
K210139 · Edan Instruments, Inc. · Oct 2021
Automatic Digital Blood Pressure Monitor
K210152 · Aviche Shandong Medical Technology Co, Ltd. · Sep 2021
Wrist Blood Pressure Monitor, Model Name:W203, Wrist Blood Pressure Monitor, Model Name:W202, Wrist Blood Pressure Monitor, Model Name:W1681
K211041 · Shenzhen Yuezhongxing Technology Co., Ltd. · Aug 2021
Digital Blood Pressure Monitor WBP Series, including: WBP101, WBP102, WBP103, WBP104, WBP105, WBP106, WBP107
K210671 · Weony (Shenzhen) Technology Co., Ltd. · Aug 2021
Caretaker Platform, VitalStream Platform, CT5
K211588 · Caretaker Medical · Aug 2021